32,726 XNAS Volume
XNAS 17 Mar, 2025 1:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 90,000 | 90,000 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 95,000 | 95,000 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 295,000 | 295,000 | - | - | Stock Option | |
| David A. Hinkle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 65,000 | 65,000 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 26,090 | 26,090 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 16,234 | 16,234 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 32,051 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 29,148 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 10,200 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 42,051 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 35,897 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 26,090 | 0 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 16,234 | 0 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 0 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 48,703 | 0 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,256 | 10,256 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 62,820 | 62,820 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 94,871 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 76,173 | 76,173 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 48,703 | 48,703 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 62,820 | 0 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 10,256 | 0 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 76,173 | 0 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 0 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 41,745 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 68,080 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 9,635 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 102,564 | 0 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 41,745 | 41,745 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 68,080 | 68,080 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 94,871 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 9,635 | 9,635 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 102,564 | 102,564 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 35,897 | 35,897 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 0 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 0 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 51,420 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 196,666 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 32,051 | 32,051 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 29,148 | 29,148 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,200 | 10,200 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 42,051 | 42,051 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 82,051 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 162,343 | 162,343 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 256,410 | 0 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 471,282 | 0 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 257,207 | 0 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 162,343 | 0 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 256,410 | 256,410 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 471,282 | 471,282 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 257,207 | 257,207 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 0 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 0 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 23,191 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 36,852 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 54,871 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 19,948 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 0 | - | - | Stock Option | |
| Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 6,610 | 6,610 | - | - | Stock Option (Right to Buy) | |
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 589,743 | 617,092 | - | - | Common Stock | ||
| Jonathan E. Lim | Director | 02 Apr 2024 | 525,274 | 550,915 | - | - | Common Stock | ||
| Jonathan E. Lim | Director | 02 Apr 2024 | 7,326 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jonathan E. Lim | Director | 02 Apr 2024 | 5,128 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jonathan E. Lim | Director | 02 Apr 2024 | 512,820 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 454,212 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 586,080 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 424,908 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 02 Apr 2024 | 133,333 | 1,181,766 | - | 16 | 2,133,328 | Common Stock |
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 1,048,433 | 1,048,433 | - | - | Common Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 787,545 | 828,570 | - | - | Common Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 02 Apr 2024 | 66,667 | 683,759 | - | 16 | 1,066,672 | Common Stock |
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 201,465 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 164,835 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 366,301 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Kristina M. Burow | Director, Ten Percent Owner | 02 Apr 2024 | 227,920 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jennifer Lew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Kristina M. Burow | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 26,438 | 26,438 | - | - | Stock Option | |
| Zachary D. Hornby | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 162,343 | 162,343 | - | - | Stock Option | |
| James Christensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 23,191 | 23,191 | - | - | Stock Option | |
| Christian Hassig | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 48,703 | 48,703 | - | - | Stock Option | |
| Jessica Oien | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 16,234 | 16,234 | - | - | Stock Option | |
| Christine Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 26,438 | 26,438 | - | - | Stock Option | |
| Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 41,745 | 41,745 | - | - | Stock Option | |
| Nancy C. Whiting | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option | |
| Jonathan E. Lim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 13,219 | 13,219 | - | - | Stock Option |